AVNS
Avanos Medical Inc · $24.99 (+0.0%) · mkt cap $1.2B
4 hub catalysts across 1 sources · backtest → · ← Ticker Explorer
SEC EDGAR Filings
Signal summary
Signals divergeBullish and bearish forces are in conflict here — weigh both columns.
39 conviction from hub signals
Bullish factors
- 2 analyst upgrades
Bearish factors
- 5 analyst downgrades
- Insiders net selling (2 vs 1)
Best strategy
2-yr backtest · by SharpeMomentum (rate-of-change) has fit AVNS best over 2 years (+129.3%, Sharpe 0.95). Historical/in-sample — walk-forward all 19 →
| # | Strategy | Return | Sharpe | Beats B&H |
|---|---|---|---|---|
| 1 | Momentum (rate-of-change) | +129.3% | 0.95 | ✓ |
| 2 | EMA Crossover | +124.7% | 0.92 | ✓ |
| 3 | Donchian Breakout | +90.7% | 0.78 | ✓ |
Price — 1 year
daily closeInsider activity
1 open-market buysOfficers & directors trading their own stock (SEC Form 4). Buys are bullish; sells shown for context.
| Date | Action | Insider | Shares | Value |
|---|---|---|---|---|
| 2025-11-18 | SELL | Holbrook Kerr | 15,000 | $165K |
| 2025-08-13 | BUY | Blackford Gary D | 60,000 | $659K |
| 2025-03-06 | SELL | Holbrook Kerr | 7,000 | $107K |
Analyst ratings
live · 9 changes| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| 2023-07-25 | Downgrade | Keybanc | Overweight → Sector Weight |
| 2023-05-22 | Initiated | CL King | Buy |
| 2021-08-04 | Downgrade | Stephens & Co. | Overweight → Equal-Weight |
| 2020-04-13 | Upgrade | Barclays | Underweight → Equal-Weight |
| 2019-11-07 | Downgrade | Stifel | Buy → Hold |
| 2019-11-06 | Downgrade | Raymond James | Outperform → Market Perform |
| 2019-01-04 | Downgrade | Barclays | Equal-Weight → Underweight |
| 2018-10-16 | Initiated | Barclays | Equal-Weight |
| 2018-08-21 | Upgrade | Raymond James | Market Perform → Outperform |
Catalyst timeline
4 hub signalsAlt-Data Signal Hub · collected signals updated 2026-07-31 09:16 UTC (refreshed daily) · market & option prices are always live on load · display-only, not advice